Pimecrolimus vs. Tacrolimus: Which Is Better for Atopic Dermatitis?
Mary Wu Chang
Abstract
Mary Wu Chang
Abstract
Pimecrolimus and tacrolimus are topical, nonsteroidal calcineurin inhibitors used in the treatment of atopic dermatitis. Pimecrolimus 1% cream is approved for patients at least 2 years old with mild-to-moderate atopic dermatitis. Tacrolimus 0.03% ointment is approved for patients at least 2 years old with moderate-to-severe atopic dermatitis, and tacrolimus 0.1% is approved for patients 16 years and older with moderate-to-severe atopic dermatitis. Few studies have compared these two …
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Pimecrolimus and tacrolimus are topical, nonsteroidal calcineurin inhibitors used in the treatment of atopic dermatitis. Pimecrolimus 1% cream is approved for patients at least 2 years old with mild-to-moderate atopic dermatitis. Tacrolimus 0.03% ointment is approved for patients at least 2 years old with moderate-to-severe atopic dermatitis, and tacrolimus 0.1% is approved for patients 16 years and older with moderate-to-severe atopic dermatitis. Few studies have compared these two …
Key concepts: Pimecrolimus, Tacrolimus, Atopic dermatitis, Medicine, Dermatology, Calcineurin, Atopy, Allergy